Please login to the form below
sepsis
This page shows the latest sepsis news and features for those working in and with pharma, biotech and healthcare.
Hancock trumpets £250m fund for AI in the health service
I want our AI lab to generate cutting-edge technology to diagnose illnesses like sepsis, stroke and heart attacks before symptoms appear,” he added.
Latest news
-
Citryll snares €15m backing for its autoimmune disease NETs
In some autoimmune disease such as lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis, it is thought that NETs inadvertently react to host cells, stimulating the release
-
Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy
TiGenix has another adipose-derived product, Cx611, which is currently undergoing a phase I/II trial in severe sepsis.
-
Takeda offers €520m for stem cell firm TiGenix
as well as additional indications such as sepsis.
-
CHMP backs Europe’s first allogeneic stem cell therapy
Along with Cx601, TiGenix has another adipose stem cell product (Cx611) in phase II trials for severe sepsis and a cardiac stem cell preparation (AlloCSC-01) heading for phase III in
-
UK Sepsis Trust named Communiqué charity of the year
Wins praise from the judges for its HCP engagement. The UK Sepsis Trust picked up the Charity, Patient or Professional Association of the Year at last week’s Comm uniqué Awards. ... Since the charity’s formation, mortality rates in the UK have
More from news
Approximately 4 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
The global antibiotic crisis: a 2020 perspective
The consequences of such severe infections include drug-resistant pneumonia and sepsis, and often prove fatal.
-
Leicester NHS Trust’s staff intranet is integral to HCPs’ working day
Clinical education is another well-used section of the intranet; while anything on infection prevention is widely viewed, for example, information on C. difficile, MRSA and sepsis.
-
30 Women Leaders in UK Healthcare (part 3)
One notable project involved Williams reformulating the active ingredient from a GSK mouthwash, chlorhexidine, into a gel to help prevent neonatal sepsis – thereby turning a similar consumer health product into a
-
Case study: 'Just Ask'
Public awareness of sepsis increased, as shown by the positive responses to the following:. ... Do you have an idea what sepsis is?’ rose from 38% to 55%.
-
Pharma deals in May 2015
The option is exercisable on completion of the phase II studies in acute kidney injury related to sepsis.
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
TiGenix appoints Dr Marie Paule Richard
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Terrence Higgins Trust appoints creative agency 11 London for new awareness campaign
Clients include Novo Nordisk, Teva, the World Health Organization, Breast Cancer Now and the UK Sepsis Trust – as well as RSPCA and the Campaign to Protect Rural England.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
